Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 5
1987 11
1988 8
1989 20
1990 20
1991 22
1992 24
1993 30
1994 16
1995 23
1996 20
1997 24
1998 11
1999 13
2000 19
2001 14
2002 27
2003 18
2004 25
2005 17
2006 21
2007 21
2008 24
2009 31
2010 40
2011 33
2012 38
2013 34
2014 35
2015 49
2016 47
2017 52
2018 54
2019 49
2020 55
2021 57
2022 51
2023 42
2024 34

Text availability

Article attribute

Article type

Publication date

Search Results

1,001 results

Results by year

Filters applied: . Clear all
Page 1
Ivermectin: a mini-review.
Johnson-Arbor K. Johnson-Arbor K. Clin Toxicol (Phila). 2022 May;60(5):571-575. doi: 10.1080/15563650.2022.2043338. Epub 2022 Feb 28. Clin Toxicol (Phila). 2022. PMID: 35225114 Review.
Ivermectin for preventing and treating COVID-19.
Popp M, Reis S, Schießer S, Hausinger RI, Stegemann M, Metzendorf MI, Kranke P, Meybohm P, Skoetz N, Weibel S. Popp M, et al. Cochrane Database Syst Rev. 2022 Jun 21;6(6):CD015017. doi: 10.1002/14651858.CD015017.pub3. Cochrane Database Syst Rev. 2022. PMID: 35726131 Free PMC article. Review.
Effect of Early Treatment with Ivermectin among Patients with Covid-19.
Reis G, Silva EASM, Silva DCM, Thabane L, Milagres AC, Ferreira TS, Dos Santos CVQ, Campos VHS, Nogueira AMR, de Almeida APFG, Callegari ED, Neto ADF, Savassi LCM, Simplicio MIC, Ribeiro LB, Oliveira R, Harari O, Forrest JI, Ruton H, Sprague S, McKay P, Guo CM, Rowland-Yeo K, Guyatt GH, Boulware DR, Rayner CR, Mills EJ; TOGETHER Investigators. Reis G, et al. N Engl J Med. 2022 May 5;386(18):1721-1731. doi: 10.1056/NEJMoa2115869. Epub 2022 Mar 30. N Engl J Med. 2022. PMID: 35353979 Free PMC article. Clinical Trial.
Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
Naggie S, Boulware DR, Lindsell CJ, Stewart TG, Slandzicki AJ, Lim SC, Cohen J, Kavtaradze D, Amon AP, Gabriel A, Gentile N, Felker GM, Jayaweera D, McCarthy MW, Sulkowski M, Rothman RL, Wilson S, DeLong A, Remaly A, Wilder R, Collins S, Dunsmore SE, Adam SJ, Thicklin F, Hanna GJ, Ginde AA, Castro M, McTigue K, Shenkman E, Hernandez AF; Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group and Investigators. Naggie S, et al. JAMA. 2023 Mar 21;329(11):888-897. doi: 10.1001/jama.2023.1650. JAMA. 2023. PMID: 36807465 Free PMC article.
Ivermectin drug induced liver injury.
Sonderup M, Mudini W, Spearman W. Sonderup M, et al. S Afr Med J. 2023 Jun 5;113(6):24-25. doi: 10.7196/SAMJ.2023.v113i6.624. S Afr Med J. 2023. PMID: 37278267 Free article.
Adverse drug reactions and ivermectin in COVID-19.
Montastruc JL. Montastruc JL. Therapie. 2022 Nov-Dec;77(6):633-634. doi: 10.1016/j.therap.2022.04.003. Epub 2022 Apr 27. Therapie. 2022. PMID: 35599192 Free PMC article. No abstract available.
The treatment of rosacea with topical ivermectin.
Ali ST, Alinia H, Feldman SR. Ali ST, et al. Drugs Today (Barc). 2015 Apr;51(4):243-50. doi: 10.1358/dot.2015.51.4.2318439. Drugs Today (Barc). 2015. PMID: 26020066 Review.
The Effect of Ivermectin on Cases of COVID-19.
Annie FH, Campbell J, Searls L, Amos J. Annie FH, et al. Cardiovasc Revasc Med. 2022 Nov;44:98-100. doi: 10.1016/j.carrev.2022.06.004. Epub 2022 Jun 17. Cardiovasc Revasc Med. 2022. PMID: 35729025 Free PMC article.
1,001 results